• Remdesivir: Published Preliminary Results Show Shorter Recovery in COVID-19 Patients
• The National Institute of Allergy and Infectious Diseases Decision to Stop the Adaptive COVID-19 Treatment Trial (ACCT-1): On Solid Ethical and Scientific Grounds
• Is Remdesivir a Potential COVID-19 Treatment?
• False-Negative Rate of RT-PCR SARS-CoV-2 Tests
• ACC, Other CV Societies Issue Guide to Safely Resume CV Procedures, Diagnostic Tests
• Downloadable Table From JACC For Safely Resuming CV Procedures, Diagnostics Tests
• Downloadable Slide Set From JACC For Safely Resuming CV Procedures, Diagnostics Tests
• MultiSociety Podcast on Reopening of CV Services
• STS/ACC TVT Registry Webinar: Rebooting Valve Programs as COVID-19 Restrictions Loosen
• MedAxiom Webinar Recording: Managing the CV Care Reemergence: Beginning to Prepare for Post-COVID Patient Care Needs – Part 1
• Front Line Experience on Reopening CV Services (Videos)
• CMS Guidance: Essential Non-COVID-19 Care in Low Incidence Areas

☼ ☼ ☼ Return to the ACC COVID-19 Hub Home Page ☼ ☼ ☼